Insulin Management System Market Size (By Product Type - Insulin Pen Injectors, Needle And Syringe, Insulin Jet Injectors, Implantable Pumps, External Insulin Pumps, Insulin Patches; By Mode Of Action - Short Acting Insulin, Intermediate Acting Insulin, Rapid Acting Insulin, Pre-Mixed Insulin; By Diabetes Type - Diabetes I, Diabetes II; By End User - Hospital & Clinics, Ambulatory Centers) - Global Industry Size, Share, Trends, And Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 180

Introduction

Diabetes is a metabolic disease in which consist of elevated blood glucose levels over a prolonged period. It is caused due to either pancreas not able to produce enough insulin or cells of the body not responding to the insulin produced. Insulin management system helps to deliver the insulin to the body of the patient. A number of different types of insulin delivery products are available in the market which includes insulin pen injectors, needle and syringe, insulin jet injectors, implantable pumps, external insulin pumps, insulin patches, and others.

 Market Dynamics

The major driving factor for the market is increasing prevalence of the diabetes. According to the report published by the WHO, in 2014, approximately 422 million people across the globe were suffering from diabetes. Additionally, obesity and smoking are the major factors for the increasing the diabetic population. Increasing number of people suffering from obesity and adoption of smoking by people have fueled the growth of the market. Moreover, increased the demand for the better treatment option, increasing healthcare expenditure, increasing government support and advancement in the technology have boosted the growth of the market during the forecast period 2018—2026.However, high costs of syringes, lack of awareness among the people is the major factors hindering the growth of the market.

In near future the market is expecting a healthy opportunity owing to the continuous increasing demand for the better and better products.

Market Classification and Overview

The global insulin management system market is majorly segmented into product type, mode of action, diabetes type, and end users.

On the basis of product type, the market is segmented into Insulin pen injectors, needle and syringe, insulin jet injectors, implantable pumps, external insulin pumps, insulin patches, and others

On the basis of mode of action, the market is segmented into short acting insulin, intermediate acting insulin, rapid acting insulin, pre-mixed insulin.

On the basis of diabetes type, the market is segmented into type-I diabetes, type-IIdiabetes.

On the basis of end users, the market is segmented into hospital & clinics, ambulatory centre, and other.

Regional Overview

Globally, the insulin management system market is segmented into North America, Europe, Asia Pacific and Latin America, Middle East & Africa.

North America is expected to dominate the insulin management system market owing to their advancement in technology, huge diabetic population and high healthcare spending. Additionally, increasing government support and presence of a huge number of players will support the growth of the market.

Europe accounts for the second leading market in the forecast period followed by the Asia Pacific. Well developed economies and huge government support in this region have driven the growth of the market.Asia Pacific region is expected to have the fastest growth during the forecast period owing to huge number of diabetic and obese population of the region. According to the International Diabetes Federation (IDF), over 60% of total global diabetic population is in Asia Pacific of which over 114 million are present in China. Additionally, increasing per capita income and increasing government support have fueled the growth of the market. LAMEA region is expected to show healthy growth during the forecast period 2018—2026. Increasing per capita income and presence of huge untapped opportunities is driving the growth of the market. Additionally, lack of medical facilities Africa region creates an opportunity for key players to expand the market in this region.

Report Coverage

Market

Insulin Management System  Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

 Product Type, Mode of Action, Diabetes Type, End Users, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

 

Market Participants

Some of the major key players in the market are Abbott, Accu-Chek, Eli Lilly, Bayer, Animas, DexCom, Medtronic, Roche, LifeScan, Novo Nordisk, Merck, Novartis, Sanofi-aventis, Takeda Pharmaceuticals, and Bristol-Myers Squibb.

Market Segmentation

Market By Product Type

  • Insulin Pen Injectors
  • Needle and syringe
  • Insulin jet injectors
  • Implantable pumps
  • External Insulin pumps
  • Insulin patches

Market By Mode of Action

  • Short acting insulin
  • Intermediate acting insulin
  • Rapid acting insulin
  • Pre-mixed insulin

Market By Diabetes Type

  • Diabetes I
  • Diabetes II

Market By End User

  • Hospital & Clinics
  • Ambulatory canters
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary